Determination of Organic Impurities in Combination Drugs


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Methodological approaches to the control of organic impurities in drugs containing two and more active pharmaceutical ingredients are reviewed. Approaches of leading foreign pharmacopoeias (British, USA, Japanese) to assessing impurity profiles in combination drugs are analyzed. The methods for assessing impurities that carry the largest safety risks for combination drugs are determined. It is demonstrated that a unified approach to the control of organic impurities in combination drugs is needed.

Sobre autores

O. Matveeva

Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation

Autor responsável pela correspondência
Email: matveeva@expmed.ru
Rússia, Moscow, 127051

E. Kovaleva

Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation

Email: matveeva@expmed.ru
Rússia, Moscow, 127051


Declaração de direitos autorais © Springer Science+Business Media New York, 2017

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies